Loading...
IGF-Binding Protein 2 – Oncogene or Tumor Suppressor?
The role of insulin-like growth factor binding protein 2 (IGFBP2) in cancer is unclear. In general, IGFBP2 is considered to be oncogenic and its expression is often observed to be elevated in cancer. However, there are a number of conflicting reports in vitro and in vivo where IGFBP2 acts in a tumor...
Na minha lista:
| Udgivet i: | Front Endocrinol (Lausanne) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4343188/ https://ncbi.nlm.nih.gov/pubmed/25774149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2015.00025 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|